June 18, 2020/Behavioral Health

Behavioral Health Complaints in Emergency Departments Plunge During COVID-19

Where did the patients go?

20-NEU-1902713-emergency-department-650×450

Cleveland Clinic emergency departments (EDs) saw a significant decrease in the numbers of patients experiencing suicidal thoughts and struggling with alcohol abuse during early days of the COVID-19 pandemic, according to a research letter recently published in the American Journal of Emergency Medicine. Investigators noted an overall 28% decrease in behavioral health visits at 20 Cleveland Clinic EDs and more than a 60% decrease in patients presenting with suicidal ideation relative to the same period in the prior year.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“These numbers are especially alarming because we actually expected these complaints to increase, given the additional stressors of a pandemic,” says co-author Baruch Fertel, MD, Director of Operations and Quality Improvement Officer for Emergency Services at Cleveland Clinic. “Mental illness doesn’t take a vacation. Where are these patients going?”

Big year-to-year drops in emergency care-seeking

Researchers conducted a retrospective review to examine all behavioral health visits across 20 Cleveland Clinic EDs over a one-month period (March 25 through April 24, 2020) during Ohio’s state-mandated stay-at-home order for COVID-19. Cleveland Clinic EDs see more than three-quarters of a million patients each year, and researchers used the shared electronic medical record to identify behavioral health visits with ICD-10 codes and behavioral complaints. They compared these data with findings from the same time period in 2019.

Between 2019 and 2020, overall ED visits decreased by 44.4%, and behavioral health ED visits decreased by 28.0%. Patients presenting with suicidal ideation decreased by 60.6% and fell from 2.03% to 1.44% of overall ED encounters from 2019 to 2020.

Advertisement

“The number of patients presenting with suicidal ideation decreased in a greater proportion than we expected,” says Donald Malone, Jr., MD, Chair of Psychiatry and Psychology and Director of the Center for Behavioral Health at Cleveland Clinic. “We must be vigilant in reminding our patients who might be afraid of visiting the ED because of COVID-19 that suicidal ideation is an emergency and that it’s safe to come to the ED for treatment.”

Researchers also found that the number of alcohol-related complaints decreased during the study period but increased as a percentage of total behavioral health ED visits, from 28.2 to 33.5%.

A call to action for patients and providers

Efforts are underway to measure the overall suicide rate during this time period and to ascertain whether patients sought alternate treatment routes — telehealth, shelters or other venues. But the overall message to patients, physicians and other providers is clear.

Advertisement

“Please reach out to your patients struggling with behavioral health issues during this time,” says Dr. Malone. “Job loss, insurance issues and isolation can exacerbate existing issues, and whether it’s telehealth or in-person visits, check in on your patient’s mental health and remind them that it’s just like any other illness.”

“Patients should also know that we have special COVID-19 procedures in place in our emergency departments, so it is safe — in fact, necessary — for them to come if they are experiencing a mental health crisis like suicidal ideation,” says Dr. Fertel.

Related Articles

Illustration of brain maze
Specialized Clinic Broadens Scope to Manage Patients with Treatment-Resistant Psychiatric Illness

Consultation service provides comprehensive care to patients with anxiety, PTSD, schizophrenia, and other high-risk disorders

23-NEU-4313658-CQD-Hero-650×450-1
December 11, 2023/Behavioral Health
American Psychiatrists Reveal Changing Attitudes About the Therapeutic Use of Classic Hallucinogens

Study shows a growing openness to the clinical potential of psychedelic treatments

23-NEU-4366965-CQD-Hero-650×450-1
November 20, 2023/Behavioral Health
Experts Stress Importance of Improved Access to Fentanyl Testing

Urine test strips and point-of-care testing may be key to slowing opioid epidemic

23-NEU-4268008-CQD-Hero-650×450-1
November 10, 2023/Behavioral Health/Research
Researchers Analyze How COVID-19 Affected Z-Drug Prescribing Patterns With and Without Opioids

Study sheds light on how clinicians addressed their patients’ pain and insomnia during the pandemic

23-NUR-3955459-NN-RecoveryInReachProgram-CQD_650x450
November 1, 2023/Behavioral Health
Pilot Program Helps Akron General Patients Find Sobriety

Recovery's in Reach provides treatment options, peer support to those struggling with alcohol and drug use

23-NEU-4313660-CQD-Hero-650×450-1
Researchers Offer New Paradigm for Managing Adult ADHD

Experts recommend task-focused strategy for monitoring treatment

23-NEU-4214118-CQD-Hero-650×450-1
October 27, 2023/Behavioral Health
75 Years Later: Cleveland Clinic Recalls Researchers’ Pivotal Role in Discovery of Serotonin

Finding changes the treatment landscape of psychiatric illness

Dylan Wint, MD
August 22, 2023/Behavioral Health
The Difficult, Essential Talk About Dementia

Patients benefit when doctors disclose with care

Ad